Form 4: NeueHealth Director Acquires Warrants Convertible to Common Stock
SEC Form 4
Ali Behbahani, a director of NeueHealth, Inc., acquired warrants convertible to common stock on October 1, 2024, with an exercise price of $0.01.
Summary
- On October 1, 2024, Ali Behbahani, a director of NeueHealth, Inc. (NEUE), acquired warrants that can be converted into common stock.
- The warrants were acquired at an exercise price of $0.01.
- The warrants are exercisable until April 30, 2029.
- The acquired warrants are indirectly held through NEA 16, NEA 17, and NEA 18 VGE.
- Mr. Behbahani disclaims beneficial ownership of the securities held by NEA 16, NEA 17, and NEA 18 VGE, except to the extent of his pecuniary interest.
- A total of 61,865 warrants were acquired related to NEA 16 and NEA 17, and 185,595 warrants were acquired related to NEA 18 VGE.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing the acquisition of warrants by a company director. It doesn't inherently convey positive or negative sentiment, but rather provides factual information about the transaction.
Industry Context
This filing is a routine disclosure related to insider transactions and is common for publicly traded companies. It provides transparency into the holdings and transactions of company insiders.
Stakeholder Impact
- The acquisition of warrants by a director could be perceived positively by shareholders as it aligns the director's interests with the company's success.
- However, the potential dilution of existing shares upon exercise of the warrants could be a concern for some shareholders.
Key Dates
| Date | Description |
|---|---|
| 2023/08/04 | Date of Credit Agreement between the Issuer and the lenders thereto. |
| 2023/10/02 | Date of Incremental Amendment No. 1 to the Credit Agreement. |
| 2024/04/08 | Date of Warrantholders Agreement between the Issuer and the holders listed on Schedule 1 thereto, and Incremental Amendment No. 2 to the Credit Agreement. |
| 2024/10/01 | Date of the transaction where warrants were acquired. |
| 2024/10/02 | Deemed execution date for the transaction. |
| 2024/10/03 | Date of signature for the Form 4 filing. |
| 2029/04/30 | Expiration date of the warrants. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.